Cargando…

Non-replicating Toxoplasma gondii reverses tumor-associated immunosuppression

We examined the efficacy of using attenuated non-replicating Toxoplasma gondii uracil auxotrophs that can be safely delivered as anticancer immunotherapeutics. This strategy exerted remarkable therapeutic activity in murine models of melanoma and ovarian carcinoma, and holds broad potential for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, Barbara A, Sanders, Kiah L, Bzik, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862683/
https://www.ncbi.nlm.nih.gov/pubmed/24353916
http://dx.doi.org/10.4161/onci.26296
_version_ 1782295772527591424
author Fox, Barbara A
Sanders, Kiah L
Bzik, David J
author_facet Fox, Barbara A
Sanders, Kiah L
Bzik, David J
author_sort Fox, Barbara A
collection PubMed
description We examined the efficacy of using attenuated non-replicating Toxoplasma gondii uracil auxotrophs that can be safely delivered as anticancer immunotherapeutics. This strategy exerted remarkable therapeutic activity in murine models of melanoma and ovarian carcinoma, and holds broad potential for the development of novel, highly effective anticancer vaccines.
format Online
Article
Text
id pubmed-3862683
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-38626832013-12-18 Non-replicating Toxoplasma gondii reverses tumor-associated immunosuppression Fox, Barbara A Sanders, Kiah L Bzik, David J Oncoimmunology Author's View We examined the efficacy of using attenuated non-replicating Toxoplasma gondii uracil auxotrophs that can be safely delivered as anticancer immunotherapeutics. This strategy exerted remarkable therapeutic activity in murine models of melanoma and ovarian carcinoma, and holds broad potential for the development of novel, highly effective anticancer vaccines. Landes Bioscience 2013-11-01 2013-10-09 /pmc/articles/PMC3862683/ /pubmed/24353916 http://dx.doi.org/10.4161/onci.26296 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Fox, Barbara A
Sanders, Kiah L
Bzik, David J
Non-replicating Toxoplasma gondii reverses tumor-associated immunosuppression
title Non-replicating Toxoplasma gondii reverses tumor-associated immunosuppression
title_full Non-replicating Toxoplasma gondii reverses tumor-associated immunosuppression
title_fullStr Non-replicating Toxoplasma gondii reverses tumor-associated immunosuppression
title_full_unstemmed Non-replicating Toxoplasma gondii reverses tumor-associated immunosuppression
title_short Non-replicating Toxoplasma gondii reverses tumor-associated immunosuppression
title_sort non-replicating toxoplasma gondii reverses tumor-associated immunosuppression
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862683/
https://www.ncbi.nlm.nih.gov/pubmed/24353916
http://dx.doi.org/10.4161/onci.26296
work_keys_str_mv AT foxbarbaraa nonreplicatingtoxoplasmagondiireversestumorassociatedimmunosuppression
AT sanderskiahl nonreplicatingtoxoplasmagondiireversestumorassociatedimmunosuppression
AT bzikdavidj nonreplicatingtoxoplasmagondiireversestumorassociatedimmunosuppression